Denise Kelly
Investment advisor Seventure Partners
Dr. Denise Kelly is an Investment Advisor at Seventure Partners, where she focuses on microbiome-related investments through the Health for Life Capital™ fund. With over 20 years of experience in gut microbiology, Denise previously served as Head of Research at the Rowett Institute and founded GT Biologics, a company dedicated to microbiome therapeutics. She brings deep scientific expertise and strategic insight to support early-stage companies developing innovative solutions in health and nutrition. Denise is passionate about translating microbiome science into impactful products that improve human health.
Seminars
Wednesday 28th January 2026
Panel Discussion: Rebuilding Investor Confidence in Microbiome Therapeutics to Unlock Capital
4:00 pm
- Highlight data-driven milestones that attract funding to unlock capital
- Structure deals to balance risk and reward for early-stage ventures to improve term-sheet appeal
- Position platforms for scalability and exit potential to attract strategic investment
Key Session
